Aequus Pharmaceuticals's total assets for Q4 2024 were C$800.28K, a decrease of -6.73% from the previous quarter. TSE:AQS total liabilities were C$7.26M for the fiscal quarter, a 2.50% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.